Olix Pharmaceuticals is a South Korea-based biotechnology company focused on researching and developing RNA interference therapeutics. Its pipeline targets areas such as fibrosis, ophthalmology, and liver-related diseases.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!